Cargando…

Abstract 33: Clinical exome sequencing in XY DSD

Background: XY DSD presents as a diagnostic dilemma, making genetic tests essential for diagnosis. Aims and Objectives: Determine diagnostic yield of clinical exome sequencing in XY DSD patients &Ascertain concordance between clinical diagnosis and genetic diagnosis in case of XY DSD. Results: 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Debaditya, Chowdhury, Subhankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067718/
http://dx.doi.org/10.4103/2230-8210.342147
_version_ 1784700067286876160
author Das, Debaditya
Chowdhury, Subhankar
author_facet Das, Debaditya
Chowdhury, Subhankar
author_sort Das, Debaditya
collection PubMed
description Background: XY DSD presents as a diagnostic dilemma, making genetic tests essential for diagnosis. Aims and Objectives: Determine diagnostic yield of clinical exome sequencing in XY DSD patients &Ascertain concordance between clinical diagnosis and genetic diagnosis in case of XY DSD. Results: 39 patients were included in this observational study. Mean age at presentation was 7.5 years. Consanguinity was present in 23 cases (59%) and 24 (61.5%) were reared as males. The median External Masculinization Score was 3/12. Commonest clinical/biochemical and genetic diagnosis was partial androgen insensitivity syndrome in 17 Patients (43.6%) and 5 patients (22.7%) respectively. Clinical Exome detected mutation in 22 cases (56.4%). In 10 cases (45.45%) the variant was pathogenic. 4 (18%) cases showed a likely pathogenic variant and 8 cases (36%) showed variant of unknown significance. Discordance between clinical and genetic diagnoses was seen in 6 (27.27%) of cases. In 17 (43.6%) cases, we failed to detect any genetic abnormalities. Conclusion: Although clinical exome sequencing picked up 56.4% of cases, it led to change in diagnosis in 27.27% cases which potentially could alter management and improve clinical outcomes. However clinical exome failed to detect mutations in significant proportion of patients.
format Online
Article
Text
id pubmed-9067718
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-90677182022-05-05 Abstract 33: Clinical exome sequencing in XY DSD Das, Debaditya Chowdhury, Subhankar Indian J Endocrinol Metab Abstracts … Esicon 2021 Background: XY DSD presents as a diagnostic dilemma, making genetic tests essential for diagnosis. Aims and Objectives: Determine diagnostic yield of clinical exome sequencing in XY DSD patients &Ascertain concordance between clinical diagnosis and genetic diagnosis in case of XY DSD. Results: 39 patients were included in this observational study. Mean age at presentation was 7.5 years. Consanguinity was present in 23 cases (59%) and 24 (61.5%) were reared as males. The median External Masculinization Score was 3/12. Commonest clinical/biochemical and genetic diagnosis was partial androgen insensitivity syndrome in 17 Patients (43.6%) and 5 patients (22.7%) respectively. Clinical Exome detected mutation in 22 cases (56.4%). In 10 cases (45.45%) the variant was pathogenic. 4 (18%) cases showed a likely pathogenic variant and 8 cases (36%) showed variant of unknown significance. Discordance between clinical and genetic diagnoses was seen in 6 (27.27%) of cases. In 17 (43.6%) cases, we failed to detect any genetic abnormalities. Conclusion: Although clinical exome sequencing picked up 56.4% of cases, it led to change in diagnosis in 27.27% cases which potentially could alter management and improve clinical outcomes. However clinical exome failed to detect mutations in significant proportion of patients. Wolters Kluwer - Medknow 2022-03 /pmc/articles/PMC9067718/ http://dx.doi.org/10.4103/2230-8210.342147 Text en Copyright: © 2022 Indian Journal of Endocrinology and Metabolism https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Abstracts … Esicon 2021
Das, Debaditya
Chowdhury, Subhankar
Abstract 33: Clinical exome sequencing in XY DSD
title Abstract 33: Clinical exome sequencing in XY DSD
title_full Abstract 33: Clinical exome sequencing in XY DSD
title_fullStr Abstract 33: Clinical exome sequencing in XY DSD
title_full_unstemmed Abstract 33: Clinical exome sequencing in XY DSD
title_short Abstract 33: Clinical exome sequencing in XY DSD
title_sort abstract 33: clinical exome sequencing in xy dsd
topic Abstracts … Esicon 2021
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067718/
http://dx.doi.org/10.4103/2230-8210.342147
work_keys_str_mv AT dasdebaditya abstract33clinicalexomesequencinginxydsd
AT chowdhurysubhankar abstract33clinicalexomesequencinginxydsd